InduPro
Seattle
About InduPro
InduPro is a biotechnology company that develops proximity-based protein therapeutics designed to influence how proteins interact on cell surfaces to address disease. The company uses proprietary discovery platforms to map spatial protein relationships and identify co-target pairs for drug development, focusing on multispecific modalities such as bispecific antibodies, antibody-drug conjugates, and T cell engagers for cancer and immune-related conditions. Its research pipeline advances candidates that leverage induced proximity mechanisms to modulate cellular signaling linked to specific disease biology. InduPro also collaborates with larger biopharma partners to apply its proximity-guided platform toward new therapeutic programs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $85.0M
- Last round: Corporate Round (Jan 2026)
- Website: induprotx.com
- Phone: 1 (206) 593-5005
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/indupro-61453 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.